Brief: LakeShore Biopharma Initiates Biologics License Application Of Pika Rabies Vaccine To The Drug Regulatory Authority Of Pakistan
07/11/2024 13:13
Nov 7 (Reuters) - LakeShore Biopharma Co Ltd H6Z0.F :
* LAKESHORE BIOPHARMA INITIATES BIOLOGICS LICENSE
APPLICATION OF
PIKA RABIES VACCINE TO THE DRUG REGULATORY AUTHORITY OF PAKISTAN
* LAKESHORE BIOPHARMA CO LTD - PIKA RABIES VACCINE GRANTED
ORPHAN
DRUG DESIGNATION BY US FDA
Source text: ID:nGNX2rKSdx
Further company coverage: H6Z0.F
(Reuters.Briefs@thomsonreuters.com)
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing